BJDX

Bluejay Diagnostics, Inc.

0.88 USD
+0.06 (+7.68%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bluejay Diagnostics, Inc. stock is up 13.21% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 March’s closed higher than February.

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.